TAVNEOS
Identification of Tavneos
| No description |
Google image searchProduct monograph
Active ingredient
avacopan, 10 MG
DIN: 02526662
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
Date: 04-NOV-2022
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AJ — Complement inhibitors (ATC, ATC/DDD)
- L04AJ05 — AVACOPAN (ATC/DDD)
